Related Experiment Video

Updated: May 24, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Efficient gene therapy based targeting system for the treatment of inoperable tumors

Thomas Wirth1, Jere Tuomas Pikkarainen, Haritha Dhammika Samaranayake

  • 1AI Virtanen Institute, University of Eastern Finland, Kuopio, Finland. thomas.wirth@uef.fi

The Journal of Gene Medicine
|March 14, 2012
PubMed
Abstract

Insights

A novel gene therapy targeting system effectively delivers biotinylated compounds to solid tumors, offering a new treatment for inoperable cancers and improving survival rates in preclinical models.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Oncology

Background:

  • Many solid tumors are inoperable, necessitating alternative therapeutic strategies.
  • Current pre-targeting methods often require tumor-specific antibody engineering.
  • A universal targeting system for solid tumors is needed.

Purpose of the Study:

  • To develop and evaluate a novel, universal gene therapy-based targeting system for solid tumors.
  • To demonstrate the in vivo expression and function of a fusion protein for targeted delivery.
  • To assess the therapeutic efficacy of this system in a preclinical cancer model.

Main Methods:

  • Utilized Semliki Forest virus and lentivirus vectors for local gene transfer of a fusion protein (LDL receptor transmembrane domains and avidin).
  • Evaluated targeting of biotinylated compounds in vitro and in vivo across three animal models.
  • Employed immunohistochemistry, SPECT, and MRI for confirmation and imaging.

Main Results:

  • Successfully demonstrated in vivo targeting of biotinylated compounds via local gene transfer using two distinct vectors.
  • Confirmed targeting efficacy through various imaging modalities and immunohistochemistry.
  • Showed significantly improved survival rates in a rat glioma model treated with this gene therapy targeting system.

Conclusions:

  • The developed gene therapy targeting system is a promising approach for treating inoperable tumors.
  • This system offers a versatile platform for both therapeutic interventions and diagnostic imaging.
  • It eliminates the need for specific antibody engineering for different tumor types.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.